Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

0.323
Delayed Data
As of Apr 23
 -0.0115 / -3.44%
Today’s Change
0.30
Today|||52-Week Range
3.36
-80.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization45.0K160.0K41.0K35.0K
 
 
 
 
 
 
Operating ExpensesGross Income-45.0K-160.0K-41.0K-35.0K
 
 
 
 
 
General Expenses10.7M8.5M7.9M9.2M
 
 
 
 
 
Research And Development7.8M7.0M6.1M7.7M
 
 
 
 
 
Total Operating Expenses10.7M8.7M7.9M9.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M-8.7M-7.9M-9.3M
 
 
 
 
 
Extraordinary Credit0.009.0M1.7M0.00
 
 
 
Extraordinary Charge-600.0K0.000.00-407.0K
 
 
 
Other Expenses97.0K-28.0K-43.0K-11.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.2M313.0K-6.3M-9.7M
 
 
 
 
 
Preferred Dividend-2.5M0.000.000.00
 
 
Net Income-11.2M313.0K-6.3M-9.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.8M10.1M10.9M13.2M
 
 
 
 
 
Shares To Calculate EPS Diluted6.8M10.1M10.9M13.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$16.24$0.03-$0.58-$0.73
 
 
 
 
 
EPS Diluted-$2.03$0.03-$0.58-$0.73